SPDR S&P Biotech ETF
123 hedge funds and large institutions have $1.6B invested in SPDR S&P Biotech ETF in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 56 reducing their positions, and 29 closing their positions.
Holders
123
Holders Change
-8
Holders Change %
-6.11%
% of All Funds
3.54%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
22
Increased
26
Reduced
56
Closed
29
Calls
$10.7M
Puts
$48.9M
Net Calls
-$38.2M
Net Calls Change
-$91.1M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$419M |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$70.1M |
| 3 |
SCM
3
Sandler Capital Management
New York
|
$20.4M |
| 4 |
4
Barclays
London,
United Kingdom
|
$41.1M |
| 5 |
5
Morgan Stanley
New York
|
$220M |
